Dr Abdul Mannan: THE “HUNGRY” LEUKAEMIA
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
“THE ‘HUNGRY’ LEUKAEMIA
When the Guardian walks out, the factory goes rogue.
As per the recent data, SETD2 is a quiet, behind-the-scenes protector:
the enzyme that places H3K36me3, keeps transcription tidy, and makes sure DNA repair actually repairs instead of improvises.
But in CML, especially as it tips toward Blast Crisis, SETD2 does a lot more than guard the blueprint.
It controls the energy supply.
What happens when SETD2 disappears?
The cell doesn’t just become unstable.
It becomes hungry.
And like any stressed factory, it stops using the clean power grid (oxidative phosphorylation) and flips on the dirty emergency generator — aerobic glycolysis.
This is the Warburg shift.
Fast, inefficient, but perfect for uncontrolled growth.
What the data actually show
When SETD2 is lost in CML models:
HK2 shoots up
PDK1 ramps up
LDHA goes into overdrive
All the enzymes that push glucose down the ‘burn-fast, grow-fast’ glycolytic pathway.
It’s not random.
Mass spectrometry shows SETD2 was normally working with:
Cell cycle regulators: CDK1, p38
DNA repair machinery: MSH2, MSH6
Metabolic enzymes: LDHA
So when SETD2 quits, all three systems fall out of sync — repair, cell cycle, and energy.
The optimistic bit
Put SETD2 back into CML CD34+ cells and something striking happens:
The metabolic shift reverses
The blast-like behaviour calms down
Colony growth drops by more than 50%
It’s like plugging the factory back into the main power grid and shutting off the emergency generator.
My understanding
Don’t just stare at the mutations.
Ask what the cell is running on.
Blast Crisis isn’t only about DNA going wrong —
it’s about metabolism going wild.
The future of treating advanced CML may lie not just in fixing the genome,
but starving the rogue factory until it behaves again.”
Stay updated with Hemostasis Today.
-
Mar 2, 2026, 07:31Thrombocytopenia in Tropical Infectious Diseases – RPTH Journal
-
Mar 1, 2026, 13:17Michael Makris։ Extraterrestrial Regolith as a Trigger of the Intrinsic Coagulation Pathway
-
Mar 1, 2026, 13:11Strategic Planning Day to Shape The Future of Thrombosis and Haemostasis – THANZ
-
Mar 1, 2026, 13:06Simon Senanu: Not Every Thrombocytopenia Is Real
-
Mar 1, 2026, 12:53Kevin Tang: Evolving Burden of CVD Across Asia and Its Broader Implications for Global Health Policy
-
Mar 1, 2026, 12:02Hassan Raza: Building Sustainable Support for People with Bleeding Disorders in Pakistan
-
Mar 1, 2026, 11:40Naradja Wissmar: Raised IL-32 as a Hint to Long-Term Immune Activation Post-COVID
-
Mar 1, 2026, 11:10Mehran Ghasemzadeh: A Novel Panel Bridging Platelet Function and Clinical Presentation in Chronic ITP
-
Mar 1, 2026, 10:47Tagreed Alkaltham: In Transfusion Medicine, Every Reaction Deserves An Answer